DIA 2017 Annual Meeting has ended

Create Your Own Event

DIA 2017 Annual Meeting

E

ermorale

8:30am CDT

#23: Signal Detection: Identifying and Managing Safety Signals S402ab #21: Successful Drug Development: Best Practices for Drug Development Planning, Agency Interactions, and Regulatory Document Writing S401bc

9:00am CDT

#43: The Good Pharmacovigilance Practices in the EU: Global Applications S405b

1:00pm CDT

#32: Preparation of Risk Evaluation and Mitigation Strategies Assessment Reports S401d

8:30am CDT

#102: The Evolution of Evidence Generation: Real-World Evidence and the Next Generation of Decision Making S100a

11:00am CDT

#110: Globalization of Medical Affairs Departments S504abc #111: Patient Engagement: 4 W's and an H N426a #117: Postmarketing Safety Studies: Approaches and Regulatory Insights S401a #121: Effective Life Cycle Management S505ab

9:30am CDT

#204: Effective Team Management in Global Trials Exhibit Hall

10:30am CDT

#221: Pharmacovigilance Inspections: Hot Topics and Proactive Approaches N230b

2:00pm CDT

#250: If You See Something (About a Clinical Trial), Do You Say Something (to Your Doctor?) S401d #254: New Considerations in Benefit-Risk Management S403ab #256: Post-Trial Access: Ensuring Patient Access Across the Development Spectrum N230b

4:00pm CDT

#280: Developing Pharmacovigilance Policy Based on Impact S401bc

10:30am CDT

#327: Multiregional Clinical Trials and the ICH E17 S402ab

2:00pm CDT

#338: Risk-Based Monitoring: Convergence of Technology, Processes, and People N226 #339: Off-Label Communications to Health Care Providers and Consumers N229 #345: Global Perspective on ICH: Part 1 of 2 N228

4:00pm CDT

#364: Risk-Based Monitoring: Convergence of Technology, Processes, and People: Panel Discussion N226 #383: Safety Issues in First-in-Human Studies S405b

10:45am CDT

#409: Trial Master File: MHRA/EMA Inspections and Sponsor Audit Learnings S402ab